EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · IEX Real-Time Price · USD
9.71
+0.25 (2.64%)
At close: Jul 26, 2024, 4:00 PM
9.89
+0.18 (1.81%)
After-hours: Jul 26, 2024, 5:32 PM EDT

EyePoint Pharmaceuticals Market Cap

EyePoint Pharmaceuticals has a market cap or net worth of $505.74 million as of July 26, 2024. Its market cap has increased by 59.39% in one year.

Market Cap
505.74M
Enterprise Value
210.87M
1-Year Change
59.39%
Ranking
Category
Stock Price
$9.71

Market Cap Chart

Since January 27, 2005, EyePoint Pharmaceuticals's market cap has increased from $388.60M to $505.74M, an increase of 30.14%. That is a compound annual growth rate of 1.36%.

History

DateMarket Cap% Change
Jul 25, 2024492.70M-39.62%
Dec 29, 2023816.00M583.99%
Dec 30, 2022119.30M-66.13%
Dec 31, 2021352.20M273.09%
Dec 31, 202094.40M-43.68%
Dec 31, 2019167.60M-6.53%
Dec 31, 2018179.30M266.67%
Dec 29, 201748.90M-16.27%
Dec 30, 201658.40M-58.82%
Dec 31, 2015141.80M17.58%
Dec 31, 2014120.60M12.71%
Dec 31, 2013107.00M279.43%
Dec 31, 201228.20M22.08%
Dec 30, 201123.10M-75.61%
Dec 31, 201094.70M44.14%
Dec 31, 200965.70M281.98%
Dec 31, 200817.20M-70.19%
Dec 31, 200757.70M-25.93%
Dec 29, 200677.90M-62.73%
Dec 30, 2005209.00M-46.22%
Jan 27, 2005388.60M-
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Valneva SE 508.14M
Pacific Biosciences of California 503.86M
Absci 503.22M
Sharecare 502.47M
Treace Medical Concepts 498.55M
Third Harmonic Bio 497.95M
COMPASS Pathways 496.85M
Nano-X Imaging 495.17M
Market Cap Rankings